Aradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDA - Business Wire
Aradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDA Business Wire
Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) submitted responses to the European Medicines Agency (EMA) Day 120 questions on 23 ...
Comments
Post a Comment